Skip to main content

Table 2 Adjusted prevalence of statin eligibility among those not on statins (N = 6043), without (Model I) and with (Model II) adjustment for access/utilization.

From: Cholesterol treatment with statins: Who is left out and who makes it to goal?

  Model I Model II
Social Risk Factor AME 95% CI P AME 95% CI P
Age group         
   21-34 (reference)         
   35 7.66 3.11 12.21 <0.01 6.74 2.61 10.88 <0.01
   45 18.96 11.72 26.20 <0.01 16.96 10.16 23.76 <0.01
   55 29.84 21.76 37.93 <0.01 26.90 19.08 34.71 <0.01
   ≥ 65 42.48 34.32 50.65 <0.01 38.28 30.35 46.20 <0.01
Female -11.54 -12.57 -10.50 <0.01 -11.69 -12.75 -10.63 <0.01
Race/Ethnicity         
   White (reference)         
   Black -0.66 -1.81 0.49 0.26 -0.57 -1.54 0.40 0.25
   Hispanic -2.62 -3.74 -1.49 0.00 -1.65 -2.99 -0.30 0.02
   Other 1.91 -1.48 5.30 0.27 2.28 -1.14 5.70 0.19
Federal Poverty Level (%)         
   <100 (reference)         
   100-149 -2.52 -4.86 -0.19 0.03 -2.22 -4.23 -0.21 0.03
   149-199 -2.53 -5.76 0.70 0.12 -2.17 -5.01 0.66 0.13
   200-299 -3.31 -5.54 -1.08 <0.01 -2.91 -4.90 -0.93 <0.01
   300-499 -5.66 -8.82 -2.49 <0.01 -5.01 -7.80 -2.21 <0.01
   ≥ 500 -3.76 -5.46 -2.06 <0.01 -3.34 -4.79 -1.89 <0.01
Education (years)         
   <12 (reference)         
   12 0.10 -1.73 1.93 0.92 -0.05 -1.66 1.56 0.95
   >12 -2.34 -3.90 -0.79 <0.01 -2.09 -3.48 -0.70 <0.01
  1. Notes: AME = adjusted average marginal effect, adjusted % difference from reference group; CI = confidence interval. All analyses adjusted for survey year. Model II also adjusted for insurance, language, usual source of care, and visit number. Source: NHANES 1999-2006